Aytu Biopharma (AYTU) Operating Income Growth (3y) (2014 - 2026)
Aytu Biopharma (AYTU) Operating Income Growth (3y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 29.31% |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 4.24% |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 0.90% |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 1.82% |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -74.25% |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 27.21% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 35.42% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Aytu Biopharma | 24.49 Mn | -2.22 Mn | 7.60 Mn | 21.98% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 21.98% |
| Dec 31, 2025 | 34.05% |
| Sep 30, 2025 | 5.95% |
| Jun 30, 2025 | 23.37% |
| Mar 31, 2025 | 26.94% |
| Dec 31, 2024 | 46.86% |
| Sep 30, 2024 | 67.74% |
| Jun 30, 2024 | 54.46% |
| Dec 31, 2023 | 36.87% |
| Sep 30, 2023 | 37.53% |
| Jun 30, 2023 | 26.52% |
| Mar 31, 2023 | -21.31% |
| Dec 31, 2022 | -11.41% |
| Sep 30, 2022 | 27.45% |
| Jun 30, 2022 | -54.65% |
| Mar 31, 2022 | -131.63% |
| Dec 31, 2021 | -35.39% |
| Sep 30, 2021 | -100.88% |
| Jun 30, 2021 | -84.60% |
| Dec 31, 2020 | -11.76% |